...
首页> 外文期刊>Bioorganic and Medicinal Chemistry Letters >Synthesis of 1-(methanesulfonyl- and aminosulfonylphenyl)acetylenes that possess a 2-(N-difluoromethyl-1,2-dihydropyridin-2-one) pharmacophore: evaluation as dual inhibitors of cyclooxygenases and 5-lipoxygenase with anti-inflammatory activity.
【24h】

Synthesis of 1-(methanesulfonyl- and aminosulfonylphenyl)acetylenes that possess a 2-(N-difluoromethyl-1,2-dihydropyridin-2-one) pharmacophore: evaluation as dual inhibitors of cyclooxygenases and 5-lipoxygenase with anti-inflammatory activity.

机译:具有2-(N-二氟甲基-1,2-二氢吡啶-2--2-酮)药效基团的1-(甲磺酰基-和氨基磺酰基苯基)乙炔的合成:具有抗炎活性的环加氧酶和5-脂氧合酶的双重抑制剂评估。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

A hitherto unknown class of linear acetylene regioisomers were designed such that a SO(2)Me or SO(2)NH(2) group was located at the ortho-, meta- or para-position of the acetylene C-1 phenyl ring, and a N-difluoromethyl-1,2-dihydropyridin-2-one moiety was attached via its C-5 position to the C-2 position on an acetylene template (scaffold). All three SO(2)Me regioisomers, and the 4-SO(2)NH(2) analog, were potent inhibitors of 5-lipoxygenase (5-LOX IC(50)=3.2-3.5 microM range) relative to the reference drug caffeic acid (IC(50)=4.0 microM). The SO(2)Me regioisomers exhibited weak cyclooxygenease-1 (COX-1) and -2 (COX-2) inhibitory activity with a modest COX-2 selectivity index. The most potent 3-SO(2)Me, 4-SO(2)Me and 4-SO(2)NH(2) compounds, with respective ED(50) values of 66.1, 68.5 and 86.5 mg/kg po, exhibited comparable oral anti-inflammatory (AI) activity to that of the reference drug ibuprofen (ED(50)=67.4 mg/kg po). The N-difluoromethyl-1,2-dihydropyridin-2-one moiety provides a novel pharmacophore for the design of cyclic hydroxamic mimetics capable of inhibiting 5-LOX for exploitation in the development of 5-LOX inhibitory AI drugs.
机译:设计迄今未知的线性乙炔区域异构体,以使SO(2)Me或SO(2)NH(2)基团位于乙炔C-1苯环的邻位,间位或对位, N-二氟甲基-1,2-二氢吡啶-2-酮部分通过其C-5位置与乙炔模板(支架)的C-2位置连接。所有三个SO(2)Me区域异构体和4-SO(2)NH(2)类似物都是相对于参考药物的5-脂氧合酶的有效抑制剂(5-LOX IC(50)= 3.2-3.5 microM范围)咖啡酸(IC(50)= 4.0 microM)。 SO(2)Me区域异构体表现出弱的环氧合酶-1(COX-1)和-2(COX-2)抑制活性与适度的COX-2选择性指数。最有效的3-SO(2)Me,4-SO(2)Me和4-SO(2)NH(2)化合物的ED(50)值分别为66.1、68.5和86.5 mg / kg po与参考药物布洛芬相当的口服抗炎(AI)活性(ED(50)= 67.4 mg / kg po)。 N-二氟甲基-1,2-二氢吡啶-2--2-酮部分为设计能够抑制5-LOX的环状异羟肟酸酯模拟物提供了一种新的药效团,可用于开发5-LOX抑制性AI药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号